Revelation Biosciences (REVB) Capital Expenditures (2021 - 2024)
Revelation Biosciences (REVB) posted quarterly Capital Expenditures of -$17689.0 for Q4 2024, down 200.01% quarter-over-quarter from $17688.0 in Q3 2024.
Revelation Biosciences (REVB) Capital Expenditures (2021 - 2024) Analysis & Trends
Revelation Biosciences (REVB) has reported Capital Expenditures for 2 consecutive years, with -$17689.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Capital Expenditures changed N/A year-over-year to -$17689.0; the TTM figure through Dec 2024 stood at $19171.0 (changed N/A YoY), while the FY2024 annual figure was $19171.0, changed N/A from the prior year.
- Capital Expenditures eased to -$17689.0 in Q4 2024 per REVB's latest filing, from $17688.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $99101.0 in Q1 2021 and bottomed at -$17689.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 251.02 Mn |
| 10 | Revelation Biosciences | 4.13 Mn | -7.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -17,689.00 |
| Dec 31, 2024 | -17,689.00 |
| Sep 30, 2024 | 17,688.00 |
| Sep 30, 2024 | 17,688.00 |
| Mar 31, 2024 | 19,172.00 |
| Mar 31, 2024 | 19,172.00 |
| Dec 31, 2021 | -16,153.00 |
| Dec 31, 2021 | -16,153.00 |
| Jun 30, 2021 | 49,015.00 |
| Jun 30, 2021 | 49,015.00 |
| Mar 31, 2021 | 99,101.00 |
| Mar 31, 2021 | 99,101.00 |